Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proinflammatory circulating molecules in peripheral arterial disease.

International journal of molecular medicine - 1 Sept 2007

Signorelli Salvatore S, Mazzarino Maria C, Spandidos Demetrios A, Malaponte Grazia

Abstract excerpt

Peripheral arterial disease (PAD) affects about 5% of the elderly population in the western world. It has been reported that PAD is associated with elevated plasma levels of the inflammatory markers. The goal of this review is to describe which proinflammatory molecules may play a role in PAD development, C-reactive protein, fibrinogen, pro-inflammatory cytokines, adhesion molecules and matrix metalloproteinases...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to C-Reactive Protein
Share to Cell Adhesion Molecules

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytokines

Share to Fibrinogen

Share to Inflammation Mediators

Share to Interleukin-6

Share to Matrix Metalloproteinases

Share to Peripheral Vascular Diseases

Source

Identifiers

PMID: 17671730

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proinflammatory circulating molecules in peripheral arterial disease.PMID 17671730Read ↗

Inflammatory Markers Related to Innate and Adaptive Immunity in Atherosclerosis: Implications for Disease Prediction and Prospective TherapeuticsSemantic proximity Read ↗

Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms, MicroRNAs and Personalized Medicine for Patients with Peripheral Arterial DiseaseSemantic proximity Read ↗

The role of biomarkers and genetics in peripheral arterial disease.Semantic proximity Read ↗

Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.Semantic proximity Read ↗

Immunological Analysis of Peripheral Artery DiseaseSemantic proximity Read ↗

Pro-inflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia.Semantic proximity Read ↗

Functional, genetic and biochemical biomarkers of peripheral arterial disease.Semantic proximity Read ↗

Association between inflammatory markers and the interleukin-6 -174 G/C polymorphism is abolished in peripheral arterial occlusive disease.Semantic proximity Read ↗

Modulation of the Inflammatory Response in Cardiovascular DiseaseSemantic proximity Read ↗

C-reactive protein, cytokines and inflammation in cardiovascular diseases.Semantic proximity Read ↗

Peripheral arterial occlusive disease: Global gene expression analyses suggest a major role for immune and inflammatory responsesSemantic proximity Read ↗

Interleukin 6 polymorphisms are associated with cardiovascular risk factors in premature coronary artery disease patients and healthy controls of the GEA Mexican study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.